You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This volume, the result of a conference cosponsored by the Brookings Institution and the American Enterprise Institute, brings together state-of-the-art methodological and empirical work on the measurement of medical outcomes and prices.
Econometrics of Health Care - which we have sometimes called 'medico metrics' - is a field in full expansion. The reasons are numerous: our knowl edge of quantitative relations in the field of health econometrics is far from being perfect, a large number of analytical difficulties - combining medical (latent factors, e. g. ) and economic facts (spatial behaviour, e. g. ) are faced by the research worker, medical and pharmaceutical techniques change rapidly, medical costs rocket more than proportionally with available resources, of being tightened. medical budgets are in the process So it is not surprising that the practice of 'hygieconometrics' - to produce a neologism - is more and more inc...
Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.
Challenging the wisdom about the way capitalism and colonialism joined forces to transform Hong Kong into one of the world's great cities, this book deploys case studies of the clash of interests between alien colonials and their Chinese constituents and the conflict between a pro-business government and its political and social responsibilities.
This work is a continuation of the authors' earlier publication, "The China Miracle: Development Strategy and Economic Reform". The authors review the historical evolution of the state-owned enterprises, analyze the current problems, and suggest the direction for future reforms.